Max Eye Hospital Private Limited
Provides medical services through a super specialty eye hospital, incorporated in 2015.
2015 | Patna, Bihar (India) | Active
Max Eye Hospital Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 5.90 M
- Revenue Growth -17.95%
- Profit Growth -1545.08%
- Ebitda -95.56%
- Net Worth -52.02%
- Total Assets -15.75%
About Max Eye Hospital
Max Eye Hospital Private Limited (MEHPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 August 2015 (Nine years and six months 9 days old ). Its registered office is in Patna, Bihar, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹5.90 M.
Amit Anand and Nishith Prakash serve as directors at the Company.
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100BR2015PTC024807
- Company No.
024807
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 2015
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Healthcare
Who are the key members and board of directors at Max Eye Hospital?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Anand  | Director | 21-Aug-2015 | Current |
| Nishith Prakash | Director | 21-Aug-2015 | Current |
Financial Performance of Max Eye Hospital.
Max Eye Hospital Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 17.95% decrease. The company also saw a substantial fall in profitability, with a 1545.08% decrease in profit. The company's net worth observed a substantial decline by a decrease of 52.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Max Eye Hospital?
In 2020, Max Eye Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹5.90 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 0.59 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Dec 2015 | Others | ₹5.90 M | Open |
How Many Employees Work at Max Eye Hospital?
Unlock and access historical data on people associated with Max Eye Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Max Eye Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Max Eye Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.